Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE)

Diabetologia

Volumn 57, Issue 11, 2014, Pages 2324-2333

  Piniés, José A ^a   González Carril, Fernando ^b   Arteagoitia, José M ^b   Irigoien, Itziar ^c   Altzibar, Jone M ^b,d   Rodriguez Murua, José L ^b   Echevarriarteun, Larraitz ^b   the Sentinel Practice Network of the Basque Country, ^e  

^a HOSPITAL DE CRUCES   (Spain)

^b Public Health Service   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e Primary Care Centres Osakidetza Basque Health Service   (Spain)

Author keywords

Calibration; Cardiovascular disease; Coronary heart disease; Discrimination; Epidemiology; Mortality; Prediction model; Type 2 diabetes mellitus; Validation

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EXTERNAL VALIDITY; FEMALE; FRAMINGHAM RISK SCORE; HEALTH SERVICE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SOUTHERN EUROPEAN; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY DISEASE; MORTALITY; THEORETICAL MODEL;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES;

EID: 84919935903     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3370-1     Document Type: Article

References (47)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
2. Arteagoitia JM, Larrañaga MI, Rodriguez JL, Fernández I, Piniés JA (2003) Incidence, prevalence and coronary heart disease risk level in known Type II diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46:899–909
3. Soriguer F, Goday A, Bosch-Comas A et al (2012) Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study. Diabetologia 55:88–93
4. World Health Organization (2008) The global burden of disease: 2004 update. Word Health Organization, Geneva
5. Selvin E, Marinopoulos S, Berkenblit G et al (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421–431
6. Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH (1992) Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820–825
7. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
8. Evans JM, Wang J, Morris AD (2002) Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 324:939–944
9. Cano JF, Baena-Diez JM, French J et al (2010) Long-term cardiovascular risk in type 2 diabetic compared with non-diabetic first acute myocardial infarction patients. Diabetes Care 33:2004–2009
10. Masiá R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, Corvas M, Aubó C, Elosua R (1998) High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGIDOR Investigators. J Epidemiol Community Health 52:707–715
11. Earl S (2011) Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S. Diabetes Care 34:1337–1343
12. Winell K, Pietilä A, Niemi M, Reunanen A, Salomaa V (2011) Trends in population attributable fraction of acute coronary syndrome and ischemic stroke due to diabetes in Finland. Diabetologia 54:2789–2794
13. Stevens RJ, Kothari V, Adler AI, Sttraton IM (2001) United Kingdom Prospective Diabetes Study (UKPDS) group. The UKDPS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 101:617–619
14. Kothari V, Steven RJ, Adler AI et al (2002) Risk of stroke in type 2 diabetes estimates by the UK prospective diabetes study risk engine. Stroke 33:1716–1781
15. Kengne AP, Patel A, Marre M et al (2011) Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 18:393–398
16. Dieren S, Peelen LM, Nöthlings U et al (2011) External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 54:264–270
17. Chauvin P (1994) Constitution and monitoring of an epidemiological surveillance network with sentinel general practitioners. Eur J Epidemiol 10:477–479
18. Green LA, Wood M, Becker L et al (1984) The ambulatory Sentinel Practice Network: purpose, methods, and policies. J Fam Pract 18:275–280
19. Larrañaga I, Arteagoitia JM, Piniés JA, Rodriguez JL, Gonzalez F, the Sentinel Surveillance Network of the Basque Country (2005) Social Inequalities in the prevalence, cardiovascular risk factors and complications or type 2 diabetes in the Basque Country (Spain). Diabet Med 22:1047–1053
20. World Health Organization Diabetes mellitus: report of a WHO study group Geneva: World Health Organization (1985) (Technical report series no. 727)
21. Alberti KG, Zimmet PZ, for the WHO Consultation (1998) Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Diabet Med 15:539–553
22. Gómez-Ambrosi J, Silva C, Galofré JC et al (2012) Body mass index classification misses subjects with increased cardio-metabolic risk factors related to elevated adiposity. Int J Obes 36:286–294
23. MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 355:765–774
24. Klein JP, Moeschberger ML (1997) Survival analysis: techniques for censored and truncated data, 1st edn. Springer Verlag, New York
25. Parzen M, Lipsitz SR (1999) A global goodness-of fit statistic for Cox regression models. Biometrics 55:580–584
26. Marrugat J, Solanas P, D’Agostino R, Sullivan L, Ordovas J, Cordón F et al (2003) Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 56:253–261 [article in Spanish]
27. Uno H, Cait T, Pencina MJ, D’Agostino RB (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 30:1105–1117
28. Collins GS, de Groot JA, Dutton S et al (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14:40
29. Smith NL, Barzily JI, Kronmal R et al (2006) New-onset diabetes and risk of all-cause and cardiovascular mortality. Diabetes Care 29:2012–2017
30. Gender RN, Gatling W, Muller MA, Byrne CD (2007) Early mortality from the time of diagnosis of Type 2 diabetes: a 5-year prospective cohort with a local age-and sex-matched comparison cohort. Diabet Med 24:1164–1167
31. Stratton DM, Adler AI, Neil HJ et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412
32. Mata-Cases M, Prado-Lacueva C, Salido-Valencia V et al (2011) Incidence of complications and mortality in type 2 diabetes cohort study followed up from diagnosis in a primary healthcare centre. Int J Clin Pract 65:299–307
33. Joutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (2008) Similarity of the impact of type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:714–719
34. Hansen LJ, Olivarius NF, Siersma V (2009) 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health 9:400–408
35. Hu G, DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly diagnosed diabetes. Diabetologia 46:608–617
36. Roche MM, Wang PP (2013) Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care 36:2582–2590
37. Regidor E, Franch J, Segul M, Serrano R, Rodriguez-Artalejo F, Artola S (2012) Traditional risk factors alone could not explain the excess mortality in patients with diabetes. Diabetes Care 35:2503–2509
38. Tanaka S, Tanaka S, Iimuro S (2013) Predicting macro- and microvascular complications in type 2 diabetes. Diabetes Care 36:1193–1199
39. De Cosmo S, Copetti M, Lamacchia O et al (2013) Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes mellitus. Diabetes Care 36:2830–2835
40. Van Dieren S, Peelen LM, Nöthlings U (2011) External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 54:264–270
41. Holman RR, Paul SK, Bethel A et al (2008) 10-year follow-up or intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589
42. The ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572
43. Ducworth W, Abraira C, Moritz T (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139
44. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington FRP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559
45. Gaede P, Lund-Andersen H, Parving H-H et al (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591
46. Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the study of Diabetes (EASD). Ryden L, Grant PJ, Anker SD et al ESC (2013) Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34:3035-3087
47. Lloyd-Jones DM (2010) Cardiovascular risk prediction. Basic concepts, current status, and future directions. Circulation 121:1768–1777